• Add this page to "Favorite pages"
  • Print Text
Here begins the text.

PMDA-ATC Pharmaceuticals Review Seminar 2018


  The Pharmaceuticals and Medical Devices Agency (PMDA) is pleased to announce the holding of the "PMDA-ATC Pharmaceuticals Review Seminar 2018" for pharmaceuticals reviewers from overseas regulatory authorities.
  The Seminar will be offered by the Asia Training Center for Pharmaceuticals and Medical Devices Regulatory Affairs (PMDA-ATC) in Tokyo and Toyama prefecture, from June 18-22, 2018.
  The Seminar will cover a wide range of topics including product review for not only new drugs but also generic drugs and biosimilars, CMC, Good Clinical Practice (GCP), Good Laboratory Practice (GLP), etc.  through the lecture and case study, aiming to provide the participants with opportunities to acquire knowledge and perspectives to enhance the regulatory system in the participants' own country or region.
  The seminar is not open to the industry or non-regulatory authorities. 
  Participation from many regulatory authorities is welcomed.

Key Seminar Objective

  1. To learn basics of regulations and regulatory organization
  2. To learn the key regulatory flow of the product development to post-approval

   The Seminar will focus on the following key regulatory activities.
    - Consultations (Scientific Advice)
    - Product review

  1. To make use of the learnings from case studies and discussions and reflect it
       back to the regulatory system in the participant's organization

Who should apply

  • Pharmaceuticals reviewers from regulatory authorities.
  • A basic knowledge of the regulations pertaining to the pharmaceutical product review in his/her organization is required.

    - The training will be provided in English (with simultaneous translation in some sessions).
    - All participants are expected to actively participate in all of the sessions.


June 18 to 22, 2018. See attached program for draft schedule.

Program (subject to change)

See attached for the draft program


  • Registration request should be made by filling in all the necessary items including signature by Head of Organization on the application form (attached).  Please send the form in both the Word file (without signature) and the PDF file (with signature) by e-mail to PMDA-ATC●pmda.go.jp
  • Registration will close on April 6, 2018.
  • Early registration is recommended. The registration may close before the deadline depending on the number of application. Also, please be sure to allow enough time to obtain the visa for entry to Japan.
  • If the number of applications exceeds the capacity, the number of participants from each country may be limited.
  • Confirmation of the registration and additional meeting information will be sent to the approved participants after the close of registration.


There is no registration fee for this seminar.
Information on travel and hotel reservation assistance will be announced to the approved participants.


Pharmaceuticals and Medical Devices Agency (PMDA):

Shin-kasumigaseki Building, 3-3-2 Kasumigaseki, Chiyoda-ku, Tokyo 100-0013, Japan
Please note that the venue of the first day is NOT PMDA office and details will be informed in due course.



Please use public transportation. Nearest Tokyo Metro Subway Stations:

  • 5 minutes' walk from Exit 11 of Toranomon Station on the Ginza Line
  • 8 minutes' walk from Exit 3 of Kokkai-gijido-mae Station, on the Marunouchi Line, Chiyoda Line
  • 8 minutes' walk from Exit A13 of Kasumigaseki Station, on the Marunouchi Line, Chiyoda Line, Hibiya Line
  • 10 minutes' walk from Exit 8 of Tameike-sanno Station, on the Ginza Line, Nanboku Line

Contact Us

For more information, please contact:

Secretariat, PMDA Asia Training Center
E-mail: PMDA-ATC●pmda.go.jp

Office of International Cooperation
Pharmaceuticals and Medical Devices Agency
Shin-Kasumigaseki Building, 3-3-2 Kasumigaseki, Chiyoda-ku, Tokyo 100-0013, Japan

(Note: For the purpose of security, @ in the e-mail addresses are replaced with ●. Please replace ● with @ when you send an e-mail.)

JCN 3010005007409

Shin-Kasumigaseki Building, 3-3-2 Kasumigaseki, Chiyoda-ku, Tokyo 100-0013 Japan


Copyright (C) Pharmaceuticals and Medical Devices Agency, All Rights Reserved.